Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Circulation. 2017 Mar 30;135(22):2119–2132. doi: 10.1161/CIRCULATIONAHA.117.027272

Figure 1. Kaplan Meir estimates of the rates of the composite global cardiovascular disease (CVD) and atherosclerotic cardiovascular disease (ASCVD) outcomes stratified by the number of abnormal test results.

Figure 1

Figure 1

Figure 1

Figure 1

Panel A: Global CVD outcome in MESA. Panel B: ACVD outcome in MESA. Panel C: Global CVD outcome in DHS. Panel D: ASCVD outcome in DHS.